Evan Loh

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) shares reacted positively following the announcement of a Food and Drug Administration's approved treatment. What To Know The company announced FDA approval of Nuzyra, for the treatment of community-acquired bacterial pneumonia (CABP), as well as...